Phase I results presented for AZD-7451 in adults with recurrent glioblastoma multiforme Nov. 28, 2014
Interferon gene signature suppression with sifalimumab and anifrolumab in patients with SLE Nov. 27, 2014
Researchers present in vivo data for a novel highly selective aldosterone synthase inhibitor Nov. 27, 2014
Phase I results demonstrate safety of CTO plus bevacizumab in patients with malignant glioma Nov. 27, 2014
RSS